Angus P. McIntyre, MD

Addison Gilbert HospitalGloucester, Massachusetts - 01930 (978-927-6850) |
- CLINICAL TRIALS 16
- CONDITIONS23
- INTERVENTIONS34
- SINCE1996

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
June 2008 - December 2009

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
August 2003 - July 2005

Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
May 2009 - December 2012

Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
August 2003 - July 2007

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
February 2008 - August 2009

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Collecting and Storing Blood Bone Marrow and Other Samples From Patients With Acute Leukemia Chronic Leukemia or Myelodysplastic Syndromes
May 1996 -

Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
May 2008 - February 2009

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Cisplatin or Carboplatin and Etoposide With or Without Sunitinib in Treating Patients With Extensive-Stage Small Cell Lung Cancer
March 2007 - November 2011

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Adenocarcinoma
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Neoplasms
Neoplasm Metastasis
Myelodysplastic Syndromes
Preleukemia
Carcinoma
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Myeloproliferative Disorders
Colorectal Neoplasms
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Placebo
Melphalan
Zoledronic Acid
Quality-Of-Life Assessment
Psychosocial Assessment And Care
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Oxaliplatin
Doxorubicin Hydrochloride
Etoposide
Sunitinib Malate
Trastuzumab
Thalidomide
Cetuximab
Biologic Sample Preservation Procedure
Tamoxifen Citrate
Irinotecan Hydrochloride
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Letrozole
Ac Regimen
Exemestane
Vinorelbine Ditartrate



